COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

Abroad (travel likely)Recruiting

Conditions

COVID-19 Recurrent · Lung Cancer · Vaccination · Antibody · Chemotherapy · Immune Checkpoint Inhibitor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, China
Contact: Study coordinator (Yan Xu, MD) · maraxu@163.com · +8618500296828

Study leads

Mengzhao Wang, MD
Principal Investigator
Peking Union Medical College Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

SARS CoV 2 Infection · COVID-19 Breakthrough · COVID-19 Recurrent

Abroad (travel likely)Recruiting

Addis Ababa, Ethiopia · Jimma, Ethiopia